Cases 1 - 8 of 8
Bausch Health Ireland Limited et al v. Mylan Laboratories Ltd. et al
as 1:2021cv00611
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Agila Specialties Inc., Mylan Pharmaceuticals Inc., Mylan Inc. and others
Cause Of Action: 35 U.S.C. § 1
Mallinckrodt IP v. Mylan Laboratories Ltd. et al
as 1:2016cv01115
Plaintiff:
Mallinckrodt IP
Defendant:
Mylan Laboratories Ltd. and Agila Specialties Inc.
Cause Of Action: 35 U.S.C. § 271
Fresenius Kabi USA, LLC et al v. Mylan Laboratories Limited et al
as 1:2015cv00942
Plaintiff:
Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH
Defendant:
Mylan Laboratories Limited, Mylan Inc., Agila Specialties Inc. and others
Cause Of Action: 35 U.S.C. § 271
Cephalon Inc. v. Sandoz Inc. et al
as 1:2015cv00178
Plaintiff:
Cephalon Inc.
Defendant:
Sandoz Inc., Accord Healthcare Inc., Intas Pharmaceuticals Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Millennium Pharmaceuticals Inc. v. Onco Therapies Limited, et al.
as 1:2015cv00040
Plaintiff:
Millennium Pharmaceuticals Inc.
Defendant:
Onco Therapies Limited and Agila Specialties Inc.
Cause Of Action: 35 U.S.C. § 271
Cadence Pharmaceuticals Inc. et al v. Agila Specialties Private Limited Inc. et al
as 1:2014cv01499
Plaintiff:
Cadence Pharmaceuticals Inc. , SCR Pharmatop and Mallinckrodt IP
Defendant:
Agila Specialties Private Limited Inc. and Agila Specialties Inc.
Cause Of Action: 35 U.S.C. § 271
Cephalon Inc. v. Agila Specialties Inc. et al.
as 1:2014cv01237
Plaintiff:
Cephalon Inc.
Defendant:
Agila Specialties Inc. and Onco Therapies Limited
Cause Of Action: 35 U.S.C. § 271
Cephalon Inc. v. Agila Specialties Inc. et al
as 1:2013cv02080
Plaintiff:
Cephalon Inc.
Defendant:
Agila Specialties Inc. and Onco Therapies Limited
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
